Comment on ‘Effect of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on survival and recurrence rates in advanced gastric cancer – a systematic review and meta-analysis’-Reference-Cited by-同舟云学术

Comment on ‘Effect of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on survival and recurrence rates in advanced gastric cancer – a systematic review and meta-analysis’

Published:2023-09-02 Issue:12 Volume:109 Page:4357-4358
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Liang Xian-Wen¹,Liu Hui²,Wu Jin-Cai¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University)

2. Department of Interventional Radiology, Central South University, Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, Hainan Province, People’s Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference5 articles.

1. Effect of hyperthermic intraperitoneal chemotherapy (HIPEC) on survival and recurrence rates in advanced gastric cancer–a systematic review and meta-analysis;Patel;Int J Surg,2023

2. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2;Miyashiro;Gastric Cancer,2011

3. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis;Geng;Cancer Med,2016

4. Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study);Bonnot;Br J Surg,2021

5. Laparoscopic distal gastrectomy and hyperthermic intraperitoneal chemotherapy in the treatment of advanced gastric cancer: a retrospective case-matched study on perioperative outcomes;Yin;J Gastrointest Oncol,2021